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1. Introduction 
a-Crystallin is one of the major proteins of the 
mammalian eye lens (for review see [ 11). The compos- 
ing polypeptide chains, A and B, of this structural 
protein undergo extensive modifications upon ageing, 
both in the ox [2,3] and, much more pronounced, in 
man [4,5]. To understand these processes, which may 
also be relevant to the formation of cataract, it is 
necessary to know the structures of the A and B chains. 
The primary structure of human cy-crystallin A chain 
has previously been determined [6]. This letter shows 
that the human Bz chain differs only in three positions 
from the already known bovine B2 chain [7], thus 
demonstrating that the B chain, like the homologous 
A chain, has a very slow rate of evolutionary change. 
The knowledge of the primary structure of human Bz 
chain will facilitate the characterization of the B-like 
chains which appear upon ageing in the human lens. 
2. Materials and methods 
a-Crystallin was isolated from aqueous extracts of 
adult human lenses by gel filtration on Sephadex G-200 
or Riogel A-SM [8]. The composing chains were sepa- 
rated by column chromatography in 6 M urea on diethyl- 
aminoethyl cellulose, at pH 8.0 [9]. The purity of 
isolated fractions was assessed by isoelectric focusing 
in 6 M urea [8], Tryptic, chymotryptic and thermo- 
lytic digestions were carried out on native B chain or 
after cleavage with cyanogen bromide [7]. Isolation of 
peptides and their analysis and sequence determination 
was carried out as described previously [lo]. 
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3. Results and discussion 
Human a-crystallin as isolated by gel-filtration shows 
a rather complex polypeptide composition [4,5]. After 
column chromatography of human a-crystallin on 
DEAE-cellulose in the presence of 6 M urea the frac- 
tion was taken, which, on the basis of analysis by isoe- 
lectric focusing, contained the polypeptide chain 
corresponding to the bovine Bz chain. Detailed results 
of our structural analyses of this chain will be given 
elsewhere [ll]. 
Peptides resulting from digestions of the human Bz 
chain or its cyanogen bromide fragments with trypsin, 
thermolysin and chymotrypsin were isolated from pep- 
tide maps. Amino acid analyses [l l] showed these pep- 
tides to be identical in composition, within 20% devia- 
tion from integral values, to the corresponding bovine 
peptides, apart from the peptides containing residues 
40,61 and 152 (fig.1). Where the bovine Bz chain 
contains alanine, isoleucine and alanine in these posi- 
tions, respectively, the human chain showed apparently 
the presence of threonine, phenylalanine and valine, 
respectively. The substitutions 61 Ile+Phe and 152 
Ala+Val were confirmed by dansyl-Edman degradation. 
The amide assignment in fig.1 is based on the 
electrophoretic mobility at pH 6.5 of peptides, apart 
from residues 25,26, 108, 109 and 110, where the 
amides are placed by homology with the bovine Bz 
chain [7]. The human Bz chain is NH2 -terminally 
blocked, probably by an acetyl group as in the bovine 
a-crystallin chains. Although serine has been reported, 
on the basis of carboxypeptidase digestions, to be the 
COOH-terminal residue of human B chains [ 121, we 
have to conclude that human Bz, like bovine Bz , has 
COOH-terminal lysine. 
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ac-Met-Asp-Ile-Ala-Ile-His-His-P~-Trp-Ile-Arg-Arg-P~-Phe-Phe-P~-Phe-His-Ser-P~-Ser-Arg-Leu-Phe-Asp-Gln-Phe-Pha-Gly- 
Tl TZa--T2b-- 
CBlTl T2 
-CBlThl--Th2--Th3- cTh4- 4 Th5 .-Th7--Th8- 
-Th6- 
-Cl--c2-- c3 
30 40 50 
-Glu-His-Leu-Leu-Glu-Ser-Asp-Leu-Phe-Pro-Thr-Ser-Thr-Ser-Leu-Ser-Pro-Phe-Tyr-Leu-Arg-Pro-P~-Ser-Phe-Leu-Arg-Ala-Pro-Ser- 
T3a T3b 
Th9 w cTh12-e -Th13 
ThlO 
- -Thlb: 
c4 
-Thll- 
c5- 
60 70 80 
-Trp-Phe-Asp-ThrGly-Leu-Ser-G1u-Met-Arg-Leu-G1u-Lys-Asp-Arg-Phe-Ser-Val-Asn-Leu-Asn-Val-Lys-His-Phe-Ser-Pro-G1u-Glu-Leu- 
* T4 -T5--T6+- Ti *- T8 
CBlThl5- -CB2Th16- --Th17+ -Th18 --Th20w+Th- 
pCB2Th19 
C6 C7 -C8- 
90 100 110 
-Lys-Val-Lys-Val-Leu-Gly-Asp-Val-Ile-Glu-Val-His-Gly-Lys-His-Glu-Glu-Arg-Gln-Asp-Glu-His-Gly-Phe-Ile-Ser-Arg-Glu-Phe-His- 
--T9-c. TlO - -Tll- - T12 * -T13- 
-21- -Th22 --Th24- Th25 *-Th26--Th- 
+Th23- 
-c9-- 
120 130 140 
-Arg-Lys-Tyr-Arg-I1e-Pro-Ala-Asp-Val-Asp-Pro-Leu-Ala-Ile-Thr-Ser-Ser-Leu-Ser-Ser-Asp-Gly-Val-Leu-Thr-Val-Asn-Gly-Pro-Arg- 
-T14-15+ 
-27-* Th29 -Th30-N Th31 Th33- 
-Th28 -Th32- 
-ClO- Cl1 -Cl2 c-Cl3 c14- 
150 160 170 
-Lys-Gln-Val-Ser-Gly-Pro-Glu-Arg-Thr-Ile-Pro-Ile-Thr-Arg-Glu-Glu-Lys-Pro-Ala-Val-Thr-Ala-Ala-P~-Lys-Lys-COOH 
-+ + + T17 - -T18 T19 ,eT20- 
T17a 
Th34 Th35 Th36 
-Th37 
-Cl5 
Fig.1. proposed amino acid sequence of the B, chain of human or-crystallin. Residues are aligned by homology with the known 
sequence of bovine B, chain [ 71 on the basis of amino acid compositions of tryptic (T), thermolytic (Th) and chymotryptic (C) 
peptides. Some peptides were obtained from B, chain treated with cyanogen bromide, resulting in the fragments CBl and CB2. 
Some steps of dansyl-Edman degradation (+) were performed on T4 and T17. This sequence differs from bovine B, by the 
substitution 40 Ala+Thr, 61 Ile+Phe and 152 Ala-tVal. 
The fact that human B2 and bovine B2 chains differ 
in 3 out of 175 positions, whereas human and bovine A 
chains differ in 10 out of 173 positions [6], indicates that 
the rate of evolution of the a-crystallin B chain is at least 
as slow as that of the A chain [13]. The A and B chains 
show 57% homology [7] and supposedly fulfill comp- 
arable roles in the a-crystallin aggregate which they 
build up together. A more detailed comparison of the 
rates and patterns of evolution of the cw-crystallin A and 
B chains might well reveal interesting aspects of evolu- 
tionary mechanisms inproteins. 
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